LITTLETON, Colo., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company specializing in the ...
H.C. Wainwright initiated coverage of Vivos Therapeutics (VVOS) with a Buy rating and $7 price target Vivos is a commercial-stage medical device company focused on the commercialization of ...
Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.
Latest SEC filings for Vivos Therapeutics, Inc. (VVOS).
Get the latest news and real-time alerts from Vivos Therapeutics, Inc. (VVOS) stock at Seeking Alpha.
See Who Won The KYM Poll For Meme Of The Month!
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback